Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
10 hedge funds and large institutions have $10.2M invested in Forward Pharma A/S American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0% more capital invested
Capital invested by funds: $10.1M → $10.2M (+$9.04K)
17% less funds holding
Funds holding: 12 → 10 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$1.98M |
| 2 |
Morgan Stanley
New York
|
+$5.71K |
| 3 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
+$838 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$725 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$559 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.96K |
FWP Hedge Fund Activity: Q3 2019 in Review
10 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q3 2019, worth a combined $10.2M — up 0.09% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FWP and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was Newtyn Management, adding an estimated $1.98M. The largest seller was BVF Inc, cutting an estimated $1.9M.
- 10 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q3 2019, down from 12 in Q2 2019.
- Funds reported $10.2M of Forward Pharma A/S American Depositary Shares stock for Q3 2019, up 0.09% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q3 2019 and 2 closed out, a net change of -2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q3 2019 was Newtyn Management, an estimated $1.98M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q3 2019 was BVF Inc, an estimated $1.9M sold.
Based on aggregated 13F filings for Q3 2019.